Jamieson Wellness (TSE:JWEL) Price Target Raised to C$42.00

Jamieson Wellness (TSE:JWEL) had its price target hoisted by National Bankshares from C$36.50 to C$42.00 in a research note issued to investors on Monday,BayStreet.CA reports.

Other research analysts have also issued reports about the stock. Canaccord Genuity Group upped their target price on shares of Jamieson Wellness from C$32.50 to C$36.25 in a report on Friday, August 9th. Royal Bank of Canada upped their price objective on shares of Jamieson Wellness from C$37.00 to C$38.00 in a research note on Friday, November 8th. BMO Capital Markets lifted their target price on shares of Jamieson Wellness from C$35.00 to C$42.00 in a research note on Friday, August 9th. Finally, TD Securities increased their price target on Jamieson Wellness from C$40.00 to C$42.00 and gave the stock a “buy” rating in a research note on Friday, November 8th.

Jamieson Wellness Stock Performance

TSE:JWEL opened at C$36.96 on Monday. The company has a current ratio of 3.21, a quick ratio of 1.08 and a debt-to-equity ratio of 92.76. The company has a market capitalization of C$1.53 billion, a P/E ratio of 42.94 and a beta of 0.63. The firm has a 50-day moving average price of C$34.79 and a two-hundred day moving average price of C$31.39. Jamieson Wellness has a twelve month low of C$23.98 and a twelve month high of C$37.24.

Jamieson Wellness Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, December 13th will be issued a dividend of $0.21 per share. This is an increase from Jamieson Wellness’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, November 29th. Jamieson Wellness’s dividend payout ratio (DPR) is presently 97.67%.

Insider Buying and Selling at Jamieson Wellness

In other Jamieson Wellness news, Senior Officer Regan Stewart sold 1,637 shares of the firm’s stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of C$35.67, for a total transaction of C$58,384.75. Also, Director Michael Al Pilato sold 24,465 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of C$33.41, for a total value of C$817,380.54. Insiders sold 32,402 shares of company stock valued at $1,100,612 over the last 90 days. 0.26% of the stock is owned by corporate insiders.

About Jamieson Wellness

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.